TECH
Bio-Techne CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.20B
P/E Ratio
98.92
EPS
$0.53
Beta
1.48
52W High
$72.06
52W Low
$45.74
50-Day MA
$60.35
200-Day MA
$57.65
Dividend Yield
0.62%
Profit Margin
6.67%
Forward P/E
24.21
PEG Ratio
0.66
About Bio-Techne Corp
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Fundamentals
| Revenue (TTM) | $1.22B |
| Gross Profit (TTM) | $809.63M |
| EBITDA | $330.54M |
| Operating Margin | 19.70% |
| Return on Equity | 3.97% |
| Return on Assets | 6.52% |
| Revenue/Share (TTM) | $7.79 |
| Book Value | $12.90 |
| Price-to-Book | 4.01 |
| Price-to-Sales (TTM) | 6.75 |
| EV/Revenue | 6.77 |
| EV/EBITDA | 36.25 |
| Quarterly Earnings Growth (YoY) | 9.10% |
| Quarterly Revenue Growth (YoY) | -0.40% |
| Shares Outstanding | $156.45M |
| Float | $154.58M |
| % Insiders | 0.29% |
| % Institutions | 113.90% |
Historical Volatility
HV 10-Day
41.59%
HV 20-Day
38.61%
HV 30-Day
42.68%
HV 60-Day
41.23%
HV Rank
48.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($75.25 target)
1
Strong Buy10
Buy4
HoldData last updated: 3/25/2026